Intercept Pharmaceuticals Inc. (ICPT)’s Positive Liver Cure Overshadows Dismal Second Quarter Results

Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) continues to soar in the market after the release of positive clinical data, which showed its drug for a lesser known liver disease is effective; increasing prospects of the same being approved by the FDA. The drug released is called OCA and was found to reverse liver damage by essentially reversing liver scarring or fibrosis, which is most of the time known to cause organ failure or cancer.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

“[…] the results are very good, better than we thought. This stock has been up a lot and what happens is I think people like exact sciences. They recognize, you know, what it is a lottery, you have a bunch of this stocks, and one of them is going to pay off, and that’s why the stock market is vibrant because when you have a great orphan drug that does do something special you can have this kind of move,” said CNBC’s Jim Cramer.

Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) has already outlined plans to release  full trial results on November 10, 2014 at the American Association study of the Liver Diseases conference in Boston. The pharmaceutical company has also outlined plans to target the drug first on Primary Biliary Cirrhosis, a rare form disease known to cause inflammation that destroys the bile ducts in the liver ultimately leading to scarring.

Intercept Pharmaceuticals Inc. (NASDAQ:ICPT)’s stock is already at a high of $295.42 having surged by 24.56% on the release of the positive news awaiting to see the final trading share price as of the close of business. Genfit another French pharmaceutical company has stated that it is developing its own experimental drug, GFT505, which treats NASH.

Genfit and Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) have also stated that plans are underway, to explore partnerships with other drug makers with a view of bringing similar treatment to the market. The release of the positive OCA drug news, looks to have overshadowed dismal quarterly results that the company posted yesterday; having posted an adjusted net loss of $1 a share compared to a net loss of $0.79 reported a year ago.

Disclosure: none

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

6 Movies That You Should Watch to Better Understand The Cold War

Top 15 Best Paying Jobs for Women in 2014

Top 6 Things Rich People Do Differently Every Day

5 Retirement Mistakes To Avoid (and Einstein’s Famous Quote)

11 Smartest People in the World

6 Films About the Financial World You Need To Watch (While “The Wolf” is Not Around)

Warren Buffett and Billionaires Are Crazy About These 7 Stocks

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top 6 Tax Scams and How to Protect Yourself

Top Businesses to Invest In

Top 5 Things You Might Be Doing Wrong With Your Business

Top 5 Strategic Technology Trends in 2014

Top Rags to Riches Stories

Parenting Behavior That Promotes Future Leaders

Top 5 Mistakes Made by Small Businesses

Top 5 Most Common and Potentially Devastating Financial Blunders

Top 5 Highest Paying Jobs for Web Designers

Top 6 Most Respected Professions that Also Pay Well

Top 5 Pitfalls Investors Should Avoid

Top 6 Lawyers and Policy Makers Under 30

Top 6 New Year’s Resolutions for Entrepreneurs

Top 7 Locations to Check in on Facebook

Top 5 Mistakes made by Rookie eBay Sellers

Top 7 eBook Publishers in 2013

Top 6 Health Industry Trends in 2014

5 Lessons for Entrepreneurs from Seth Godin

Top 5 Success Tips from Jordan Belfort – the Wolf of Wall Street

Best Master’s in Finance Degree Programs

Top 6 Earning Celebrities Over 50

The most expensive sports to play

Top 7 Earning Celebrities Under 25

Best 7 Online Courses to Take: Free Finance MOOCs

Top 6 Bad Habits that Promote Failure

20 Most Valuable Soccer Teams in the World in 2013

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!